July 2026
Psychedelic-assisted therapy
What July 2026's 8 new studies found, synthesized from the papers below. All Psychedelic-assisted therapy research →
The synthesis
Synthesized from 8 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for Psychedelic-assisted therapy, psychedelic therapy, assisted psychotherapy, psychedelic-assisted psychotherapy, then ranked by relevance.
Research in July 2026 indicates that psychedelic-assisted therapy shows promise for reducing trauma-related symptoms, including those stemming from discrimination, and for improving distress in cancer patients, though evidence is limited by small samples and methodological constraints. Studies also highlight a growing interest and perceived need for formal training among psychology students and alumni, as well as the importance of attitudes in shaping treatment expectations. Overall, findings are preliminary and underscore the need for larger, more rigorous trials and standardized training.
Evidence by study
Direction is which way each study's own result points, not our rating of the study.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| Understanding treatment expectations toward emerging therapies in veterinary medicine: the role of knowledge, attitudes, and beliefs toward psychedelic-assisted interventions 2026 | cross-sectional survey | 87 | Supports | Positive attitudes toward psychedelics were the strongest predictor of favorable treatment expectations for psychedelic-assisted therapies among veterinary students. |
| Psychedelic-Assisted Psychotherapy Education at GSPP: Assessing PsyD Student and Alumni Interest, Attitudes, and Perceived Training Needs 2026 | exploratory survey | Supports | Substantial interest in psychedelic-assisted psychotherapy education exists among students and alumni, with a perceived gap between the expansion of psychedelic medicine and current formal training. | |
| Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK. 2026 | editorial | Supports | Argues that psychedelic therapy can alleviate end-of-life distress and reduce suicidality, advocating for rescheduling psychedelics to enable research before institutionalizing assisted suicide in the UK. | |
| Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder. 2026 | preliminary study | 5 | Supports | MDMA-assisted therapy significantly reduced discrimination-related trauma symptoms, with a 38% decrease in TSDS scores and a large effect size (Cohen's d = 1.28). |
| Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study 2026 | case study | 1 | Supports | Mystical-type experiences during ketamine-assisted psychotherapy appeared to play a meaningful role in therapeutic change for a patient with generalized anxiety disorder and migraines. |
| Reframing distress in oncology: the potential of psychedelic-assisted therapy. 2026 | review | Supports | Psychedelic-assisted therapy shows promise for improving anxiety, depression, pain-related distress, and quality of life in advanced cancer patients, but evidence is limited by small sample sizes and methodological constraints. | |
| Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature 2026 | descriptive systematic review | 335 | Supports | MDMA-assisted psychotherapy may have applicability beyond PTSD, with potential benefits for complex PTSD and borderline personality disorder, though no studies directly assessed these conditions. |
| Practical Considerations for Psychedelic-Assisted Therapy among Social Workers. 2026 | theoretical or philosophical paper | Supports | Argues that social workers require specific training and ethical guidelines to safely incorporate psychedelic-assisted therapy into practice. |
Positive attitudes toward psychedelics were the strongest predictor of favorable treatment expectations for psychedelic-assisted therapies among veterinary students.
cross-sectional survey Sample size: 87
Substantial interest in psychedelic-assisted psychotherapy education exists among students and alumni, with a perceived gap between the expansion of psychedelic medicine and current formal training.
exploratory survey
Argues that psychedelic therapy can alleviate end-of-life distress and reduce suicidality, advocating for rescheduling psychedelics to enable research before institutionalizing assisted suicide in the UK.
editorial
MDMA-assisted therapy significantly reduced discrimination-related trauma symptoms, with a 38% decrease in TSDS scores and a large effect size (Cohen's d = 1.28).
preliminary study Sample size: 5
Mystical-type experiences during ketamine-assisted psychotherapy appeared to play a meaningful role in therapeutic change for a patient with generalized anxiety disorder and migraines.
case study Sample size: 1
Psychedelic-assisted therapy shows promise for improving anxiety, depression, pain-related distress, and quality of life in advanced cancer patients, but evidence is limited by small sample sizes and methodological constraints.
review
MDMA-assisted psychotherapy may have applicability beyond PTSD, with potential benefits for complex PTSD and borderline personality disorder, though no studies directly assessed these conditions.
descriptive systematic review Sample size: 335
Argues that social workers require specific training and ethical guidelines to safely incorporate psychedelic-assisted therapy into practice.
theoretical or philosophical paper
Points of agreement
- Psychedelic-assisted therapy shows promise for reducing trauma-related symptoms and improving distress in various populations.
- There is a perceived gap between the expansion of psychedelic medicine and current formal training or education.
- Positive attitudes toward psychedelics are associated with favorable treatment expectations.
Conflicts
- No direct contradictions among the studies; however, the systematic review notes that no studies directly assessed CPTSD or BPD, while the preliminary study on discrimination-related trauma had a very small sample, limiting generalizability.
Gaps
- Durability of effects beyond short-term follow-up is not addressed.
- Larger, more diverse cohorts are needed to confirm preliminary findings.
- Standardized training and ethical guidelines for practitioners are lacking.
- Direct studies on complex PTSD and borderline personality disorder are missing.
- Blinding and control for expectancy effects are not consistently addressed.